Thank you for sharing Niele! This is excellent and

Thank you for sharing Niele! This is excellent and very promising news, but unless I’m mistaken (let’s see what Ohm has to say), I believe the drug your link refers to is only applicable for something called the “MSI mutation” of that type of cancer. This mutation is rare. Only 10% of those cancer patients have this type. 90% have MSS (“Microsatellite Stable”). So this drug only works on a small population with a rare form, unfortunately. But it is definitely fantastic news for those 10% if it’s proven to work safely in that patient population!

FYI — “In the US, some 46,220 people are diagnosed with rectal cancer each year, and up to 10% are dMMR/MSI-H cancers.”

So it sounds like approximately 5,000 people annually are afflicted with this specific form of cancer. It would be phenomenal news for those patients if this drug ultimately gets approved for that indication. Let’s hope it does!